In other words GLP-1s and there are a range of these treatments all have an effect which is predominantly around high sugars and if the sugar becomes low, the effect is switched off, and it is the reason we see very low rates of low blood sugars so called 'hypos', or hypoglycemic episodes that occur with GLP1 treatments
Mioduchoski, FNP-BC Clinical Oversight: Dr
Month 4: Steady Progress (1 mg dose) Average weight loss: 6-8% cumulative (12-16 pounds for a 200-pound person) Around week 12-16, your provider will increase your dose to 1 mg weekly
The trial demonstrated a 20% reduction in the primary composite endpoint of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke (hazard ratio 0.80, 95% CI 0.72-0.90).[1] The trial also demonstrated improvements in multiple cardiovascular biomarkers independent of weight loss
They dont cause you to lose weight in and of themselves to get that effect you have to have an overarching change in your lifestyle. Its also worth noting that users will typically need to maintain their dose for the effects to last
